The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

Lignende værker

• Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
  af: Dorte B. Zilstorff, et al.
  Udgivet: (2024-03-01)
• The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
  af: Jonathan D. Douros, et al.
  Udgivet: (2025-02-01)
• A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans
  af: Brian Finan, et al.
  Udgivet: (2025-06-01)
• Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
  af: Sara Baldassano, et al.
  Udgivet: (2019-08-01)
• GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?
  af: Grazia Piras, et al.
  Udgivet: (2026-03-01)